Podiatrists in Placerville, CA Accepting Medicare

3 Podiatrists found. Showing 1 - 3

El Dorado Foot Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3175 Turner St, Placerville, CA 95667 Phone: 916-835-2724    Fax: 916-351-5674

Thomas William Wolff, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5168 Honpie Rd, Placerville, CA 95667 Phone: 530-621-3163    Fax: 916-351-5674

Victor R Sucheski Dpm Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1110 Corker Street, Placerville, CA 95667 Phone: 530-626-5062    Fax: 530-626-4130

News Archive

HTA executes purchase and sale agreement to acquire five building medical office portfolio in Indiana

Healthcare Trust of America, Inc., a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a five building medical office portfolio located in Evansville, Indiana. The closing of the acquisition is subject to the satisfaction of a number of conditions.

Telehealth plays an important role in preventing the spread of COVID-19

Rural hospitals are more likely than urban facilities to have access to telehealth, a once-underused service that now is playing a key role in treating coronavirus patients, according to research by two health administration professors in Florida Atlantic University's College of Business.

UVA researchers identify promising target for treating glioblastoma

Researchers at the University of Virginia Cancer Center have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts to develop effective treatments for this deadliest of cancers.

Octapharma USA launches wilate replacement therapy Web site for von Willebrand Disease

Octapharma USA has launched a comprehensive Web site for wilate® at www.wilateusa.com to provide von Willebrand disease healthcare professionals and patients with easily accessible information, news and updates. The U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for wilate® (von Willebrand Factor/Factor VIII Concentrate, Human), the first replacement therapy developed specifically for von Willebrand Disease (VWD).

Spectranetics plans multi-center, randomized clinical trial program for in-stent restenosis

The Spectranetics Corporation today announced its clinical trial plans related to the treatment of in-stent restenosis (ISR) in arteries above the knee, which remains a major unsolved medical problem. There is no device currently cleared or approved by the FDA to treat ISR.

Read more Medical News

› Verified 6 days ago